Oxford Gene Technology SureSeq MyPanel NGS Custom FH Panel
Oxford Gene Technology has launched the SureSeq myPanel NGS Custom FH panel for the study of variants in familial hypercholesterolemia (FH). The panel includes exons for LDLR, PCSK9, APOB, LDLRAP1, APOE, LIPA, STAP1 and 14 additional single nucleotide polymorphisms associated with FH. It delivers single nucleotide variation and copy number variation detection on a single small panel and allows customization by 'mix and match' of fully-optimized genes and hotspot content, which enables researchers to selectively sequence relevant regions, the company said.
Invitae Breast Cancer STAT Panel Expansion
Invitae has launched an expansion of its Breast Cancer STAT panel. The expansion contains two additional breast cancer predisposition genes — ATM and CHEK2 — and a faster turnaround time with results available in as few as five days at no additional cost. The cancer panel also includes seven well-established genes associated with a significantly increased risk of developing breast cancer: BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, and TP53. Testing is available for both blood and saliva samples.
GATC Biotech InView Human Exome Explore
GATC Biotech, a Constance, Germany-based sequencing services company, has launched a human exome sequencing service, InView Human Exome Explore. Sequencing is performed under diagnostic standards and includes protocols for hard-to-capture exons. Customers also have the option of including Qiagen's Ingenuity Variant Analysis for biological interpretation.
For more new products and services, please visit the New Products page on our website.